| Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials JY Chang, S Senan, MA Paul, RJ Mehran, AV Louie, P Balter, HJM Groen, ... The Lancet Oncology 16 (6), 630-637, 2015 | 1170 | 2015 |
| Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial DA Palma, R Olson, S Harrow, S Gaede, AV Louie, C Haasbeek, L Mulroy, ... The Lancet 393 (10185), 2051-2058, 2019 | 807 | 2019 |
| Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic … DR Gomez, GR Blumenschein Jr, JJ Lee, M Hernandez, R Ye, ... The lancet oncology 17 (12), 1672-1682, 2016 | 629 | 2016 |
| Local consolidative therapy vs. maintenance therapy or observation for patients with oligometastatic non–small-cell lung cancer: long-term results of a multi-institutional … DR Gomez, C Tang, J Zhang, GR Blumenschein Jr, M Hernandez, JJ Lee, ... Journal of Clinical Oncology 37 (18), 1558, 2019 | 495 | 2019 |
| Reviews of evidence regarding interventions to reduce tobacco use and exposure to environmental tobacco smoke DP Hopkins, PA Briss, CJ Ricard, CG Husten, VG Carande-Kulis, ... American journal of preventive medicine 20 (2), 16-66, 2001 | 303 | 2001 |
| Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of Oligometastatic Cancers: Long-Term Results of the SABR-COMET Randomized Trial DA Palma, RA Olson, S Harrow, S Gaede, AV Louie, C Haasbeek, ... International Journal of Radiation Oncology, Biology, Physics 108 (3), S88-S89, 2020 | 188 | 2020 |
| Detection of local cancer recurrence after stereotactic ablative radiation therapy for lung cancer: physician performance versus radiomic assessment SA Mattonen, DA Palma, C Johnson, AV Louie, M Landis, G Rodrigues, ... International Journal of Radiation Oncology* Biology* Physics 94 (5), 1121-1128, 2016 | 117 | 2016 |
| Inter-observer and intra-observer reliability for lung cancer target volume delineation in the 4D-CT era AV Louie, G Rodrigues, J Olsthoorn, D Palma, E Yu, B Yaremko, B Ahmad, ... Radiotherapy and Oncology 95 (2), 166-171, 2010 | 115 | 2010 |
| Management of early-stage non-small cell lung cancer using stereotactic ablative radiotherapy: controversies, insights, and changing horizons AV Louie, DA Palma, M Dahele, GB Rodrigues, S Senan Radiotherapy and Oncology 114 (2), 138-147, 2015 | 111 | 2015 |
| Stereotactic ablative radiation therapy for the comprehensive treatment of oligometastatic tumors (SABR-COMET): results of a randomized trial DA Palma, RA Olson, S Harrow, S Gaede, AV Louie, C Haasbeek, ... International Journal of Radiation Oncology, Biology, Physics 102 (3), S3-S4, 2018 | 97 | 2018 |
| Post-treatment mortality after surgery and stereotactic body radiotherapy for early-stage non–small-cell lung cancer WA Stokes, MR Bronsert, RA Meguid, MG Blum, BL Jones, M Koshy, ... Journal of clinical oncology 36 (7), 642-651, 2018 | 87 | 2018 |
| Stereotactic body radiotherapy versus surgery for medically operable stage I non–small-cell lung cancer: a Markov model–based decision analysis AV Louie, G Rodrigues, M Hannouf, GS Zaric, DA Palma, JQ Cao, ... International Journal of Radiation Oncology* Biology* Physics 81 (4), 964-973, 2011 | 84* | 2011 |
| Definitive radiation therapy in locally advanced non-small cell lung cancer: Executive summary of an American Society for Radiation Oncology (ASTRO) evidence-based clinical … G Rodrigues, H Choy, J Bradley, KE Rosenzweig, J Bogart, WJ Curran Jr, ... Practical radiation oncology 5 (3), 141-148, 2015 | 80 | 2015 |
| Patient reported outcomes following stereotactic ablative radiotherapy or surgery for stage IA non-small-cell lung cancer: Results from the ROSEL multicenter randomized trial AV Louie, E van Werkhoven, H Chen, EF Smit, MA Paul, J Widder, ... Radiotherapy and Oncology 117 (1), 44-48, 2015 | 78 | 2015 |
| Stereotactic ablative radiotherapy for the comprehensive treatment of 4–10 oligometastatic tumors (SABR-COMET-10): study protocol for a randomized phase III trial DA Palma, R Olson, S Harrow, RJM Correa, F Schneiders, CJA Haasbeek, ... BMC cancer 19 (1), 1-15, 2019 | 73 | 2019 |
| Treatment-related toxicity in patients with early-stage non-small cell lung cancer and coexisting interstitial lung disease: a systematic review H Chen, S Senan, EJ Nossent, RG Boldt, A Warner, DA Palma, AV Louie International Journal of Radiation Oncology* Biology* Physics 98 (3), 622-631, 2017 | 71 | 2017 |
| New strategies in stereotactic radiotherapy for oligometastases DA Palma, AV Louie, GB Rodrigues Clinical Cancer Research 21 (23), 5198-5204, 2015 | 70 | 2015 |
| Pooled analysis of stereotactic ablative radiotherapy for primary renal cell carcinoma: A report from the International Radiosurgery Oncology Consortium for Kidney (IROCK) S Siva, AV Louie, A Warner, A Muacevic, S Gandhidasan, L Ponsky, ... Cancer 124 (5), 934-942, 2018 | 69 | 2018 |
| Radiotherapy for renal cell carcinoma: renaissance of an overlooked approach S Siva, G Kothari, A Muacevic, AV Louie, BJ Slotman, BS Teh, SS Lo Nature Reviews Urology 14 (9), 549-563, 2017 | 64 | 2017 |
| Thoracic radiotherapy for extensive stage small-cell lung cancer: a meta-analysis DA Palma, A Warner, AV Louie, S Senan, B Slotman, GB Rodrigues Clinical lung cancer 17 (4), 239-244, 2016 | 61 | 2016 |
David PalmaWestern UniversityVerified email at lhsc.on.ca
